{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:37:46Z","timestamp":1770230266089,"version":"3.49.0"},"reference-count":129,"publisher":"IMR Press","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Sj\u00f6gren\u2019s syndrome (SS) is an autoimmune disease that can be classified as an epithelitis based on the immune-mediated attack directed specifically at epithelial cells. SS predominantly affects women, is characterized by the production of highly specific circulating autoantibodies, and the major targets are the salivary and lachrymal glands. Although a genetic predisposition has been amply demonstrated for SS, the etiology remains unclear. The recent integration of epigenetic data relating to autoimmune diseases opens new therapeutic perspectives based on a better understanding of the molecular processes implicated. In the autoimmune field, non-coding RNA molecules (nc-RNA), which regulate gene expression by binding to mRNAs and could have a therapeutic value, have aroused great interest. The focus of this review is to summarize the biological functions of nc-RNAs in the pathogenesis of SS and decode molecular pathways implicated in the disease, in order to identify new therapeutic strategies.<\/jats:p>","DOI":"10.31083\/j.fbl2912403","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:37:01Z","timestamp":1735558621000},"source":"Crossref","is-referenced-by-count":1,"title":["Epigenetic Modulations of Non-Coding RNAs: A Novel Therapeutic Perspective in Sj\u04e7gren\u2019s Syndrome"],"prefix":"10.31083","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-1121","authenticated-orcid":true,"given":"Margherita","family":"Sisto","sequence":"first","affiliation":[{"name":"Department of Translational Biomedicine and Neuroscience (DiBraiN), Section of Human Anatomy and Histology, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Lisi","sequence":"first","affiliation":[{"name":"Department of Translational Biomedicine and Neuroscience (DiBraiN), Section of Human Anatomy and Histology, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bird A. Perceptions of epigenetics. Nature. 2007; 447: 396\u2013398.","DOI":"10.1038\/nature05913"},{"key":"ref2","unstructured":"Moosavi A, Motevalizadeh Ardekani A. Role of Epigenetics in Biology and Human Diseases. Iranian Biomedical Journal. 2016; 20: 246\u2013258."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Bure IV, Nemtsova MV, Kuznetsova EB. Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis. International Journal of Molecular Sciences. 2022; 23: 5801.","DOI":"10.3390\/ijms23105801"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Routsias JG, Tzioufas AG, Moutsopoulos HM. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clinica Chimica Acta. 2004; 340: 1\u201325.","DOI":"10.1016\/j.cccn.2003.10.011"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kelly AL, Nelson RJ, Sara R, Alberto S. Sj\u00f6gren Syndrome: New Insights in the Pathogenesis and Role of Nuclear Medicine. Journal of Clinical Medicine. 2022; 11: 5227.","DOI":"10.3390\/jcm11175227"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sisto M, Ribatti D, Lisi S. Understanding the Complexity of Sj\u00f6gren\u2019s Syndrome: Remarkable Progress in Elucidating NF-\u03baB Mechanisms. Journal of Clinical Medicine. 2020; 9: 2821.","DOI":"10.3390\/jcm9092821"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mariette X, Criswell LA. Primary Sj\u00f6gren\u2019s Syndrome. The New England Journal of Medicine. 2018; 378: 931\u2013939.","DOI":"10.1056\/NEJMcp1702514"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Stergiou IE, Poulaki A, Voulgarelis M. Pathogenetic Mechanisms Implicated in Sj\u00f6gren\u2019s Syndrome Lymphomagenesis: A Review of the Literature. Journal of Clinical Medicine. 2020; 9: 3794.","DOI":"10.3390\/jcm9123794"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kerttula TO, Collin P, Polvi A, Korpela M, Partanen J, M\u00e4ki M. Distinct immunologic features of Finnish Sj\u00f6gren\u2019s syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma\/delta subsets. Arthritis and Rheumatism. 1996; 39: 1733\u20131739.","DOI":"10.1002\/art.1780391017"},{"key":"ref10","unstructured":"Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. Fas and Fas ligand gene polymorphisms in primary Sj\u00f6gren\u2019s syndrome. The Journal of Rheumatology. 2000; 27: 2397\u20132405."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Renaudineau Y, Ballestar E. Epigenetics: DNA methylation signatures in Sj\u00f6gren syndrome. Nature Reviews. Rheumatology. 2016; 12: 565\u2013566.","DOI":"10.1038\/nrrheum.2016.144"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Thabet Y, Le Dantec C, Ghedira I, Devauchelle V, Cornec D, Pers JO, et al. Epigenetic dysregulation in salivary glands from patients with primary Sj\u00f6gren\u2019s syndrome may be ascribed to infiltrating B cells. Journal of Autoimmunity. 2013; 41: 175\u2013181.","DOI":"10.1016\/j.jaut.2013.02.002"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bordron A, Charras A, Le Dantec C, Renaudineau Y. Influence of epigenetic in Sj\u00f6gren\u2019s syndrome. La Revue De Medecine Interne. 2018; 39: 346\u2013351.","DOI":"10.1016\/j.revmed.2017.09.003"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Charras A, Konsta OD, Le Dantec C, Bagacean C, Kapsogeorgou EK, Tzioufas AG, et al. Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome. Annals of the Rheumatic Diseases. 2017; 76: 625\u2013628.","DOI":"10.1136\/annrheumdis-2016-210167"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Argyropoulou OD, Tzioufas AG. Update on Sj\u00f6gren\u2019s Syndrome 2018. Mediterranean Journal of Rheumatology. 2018; 29: 193\u2013198.","DOI":"10.31138\/mjr.29.4.193"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Thorlacius GE, Bj\u00f6rk A, Wahren-Herlenius M. Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nature Reviews. Rheumatology. 2023; 19: 288\u2013306.","DOI":"10.1038\/s41584-023-00932-6"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Martin-Gutierrez L, Wilson R, Castelino M, Jury EC, Ciurtin C. Multi-Omic Biomarkers for Patient Stratification in Sjogren\u2019s Syndrome-A Review of the Literature. Biomedicines. 2022; 10: 1773.","DOI":"10.3390\/biomedicines10081773"},{"key":"ref18","unstructured":"Bolstad AI, Haga HJ, Wassmuth R, Jonsson R. Monozygotic twins with primary Sj\u00f6gren\u2019s syndrome. The Journal of Rheumatology. 2000; 27: 2264\u20132266."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, et al. Genome-wide association study identifies Sj\u00f6gren\u2019s risk loci with functional implications in immune and glandular cells. Nature Communications. 2022; 13: 4287.","DOI":"10.1038\/s41467-022-34311-8"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Harley ITW, Allison K, Scofield RH. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans. Frontiers in Immunology. 2022; 13: 953439.","DOI":"10.3389\/fimmu.2022.953439"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, et al. A new MHC-linked susceptibility locus for primary Sj\u00f6gren\u2019s syndrome: MICA. Human Molecular Genetics. 2017; 26: 2565\u20132576.","DOI":"10.1093\/hmg\/ddx135"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM. HLA and Sj\u00f6gren\u2019s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmunity Reviews. 2012; 11: 281\u2013287.","DOI":"10.1016\/j.autrev.2011.10.002"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annual Review of Genomics and Human Genetics. 2013; 14: 301\u2013323.","DOI":"10.1146\/annurev-genom-091212-153455"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Sundaresan B, Shirafkan F, Ripperger K, Rattay K. The Role of Viral Infections in the Onset of Autoimmune Diseases. Viruses. 2023; 15: 782.","DOI":"10.3390\/v15030782"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sj\u00f6gren\u2019s syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis and Rheumatism. 2003; 48: 2240\u20132245.","DOI":"10.1002\/art.11103"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome. Nature Genetics. 2013; 45: 1284\u20131292.","DOI":"10.1038\/ng.2792"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren\u2019s syndrome at 7q11.23. Nature Genetics. 2013; 45: 1361\u20131365.","DOI":"10.1038\/ng.2779"},{"key":"ref28","unstructured":"Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, et al. Genetic and clinical basis for two distinct subtypes of primary Sj\u00f6gren\u2019s syndrome. Rheumatology. 2021; 60: 837\u2013848."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G. Genetics and epigenetics in primary Sj\u00f6gren\u2019s syndrome. Rheumatology. 2021; 60: 2085\u20132098.","DOI":"10.1093\/rheumatology\/key330"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, et al. NCR3\/NKp30 contributes to pathogenesis in primary Sjogren\u2019s syndrome. Science Translational Medicine. 2013; 5: 195\u2013196.","DOI":"10.1126\/scitranslmed.3005727"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Bolstad AI, Le Hellard S, Kristjansdottir G, Vasaitis L, Kvarnstr\u00f6m M, Sj\u00f6wall C, et al. Association between genetic variants in the tumour necrosis factor\/lymphotoxin \u03b1\/lymphotoxin \u03b2 locus and primary Sjogren\u2019s syndrome in Scandinavian samples. Annals of the Rheumatic Diseases. 2012; 71: 981\u2013988.","DOI":"10.1136\/annrheumdis-2011-200446"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Taylor KE, Wong Q, Levine DM, McHugh C, Laurie C, Doheny K, et al. Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sj\u00f6gren\u2019s Syndrome According to Ancestry. Arthritis & Rheumatology. 2017; 69: 1294\u20131305.","DOI":"10.1002\/art.40040"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Toledo-Stuardo K, Ribeiro CH, Canals A, Morales M, G\u00e1rate V, Rodr\u00edguez-Siza J, et al. Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer. Frontiers in Immunology. 2021; 12: 645528.","DOI":"10.3389\/fimmu.2021.645528"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Abramowitz LK, Olivier-Van Stichelen S, Hanover JA. Chromosome imbalance as a driver of sex disparity in disease. Journal of Genomics. 2014; 2: 77\u201388.","DOI":"10.7150\/jgen.8123"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Harris VM, Sharma R, Cavett J, Kurien BT, Liu K, Koelsch KA, et al. Klinefelter\u2019s syndrome (47,XXY) is in excess among men with Sj\u00f6gren\u2019s syndrome. Clinical Immunology. 2016; 168: 25\u201329.","DOI":"10.1016\/j.clim.2016.04.002"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, et al. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sj\u00f6gren\u2019s Syndrome. Arthritis & Rheumatology. 2016; 68: 1290\u20131300.","DOI":"10.1002\/art.39560"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Sharma R, Harris VM, Cavett J, Kurien BT, Liu K, Koelsch KA, et al. Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sj\u00f6gren\u2019s Syndrome. Arthritis & Rheumatology. 2017; 69: 2187\u20132192.","DOI":"10.1002\/art.40207"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, et al. The CGGGG insertion\/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sj\u00f6gren\u2019s syndrome. Arthritis and Rheumatism. 2009; 60: 1991\u20131997.","DOI":"10.1002\/art.24662"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, et al. STAT4 is a confirmed genetic risk factor for Sj\u00f6gren\u2019s syndrome and could be involved in type 1 interferon pathway signaling. Genes and Immunity. 2010; 11: 432\u2013438.","DOI":"10.1038\/gene.2010.29"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Nordmark G, Kristjansdottir G, Theander E, Eriksson P, Brun JG, Wang C, et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj\u00f6gren\u2019s syndrome. Genes and Immunity. 2009; 10: 68\u201376.","DOI":"10.1038\/gene.2008.94"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sj\u00f6gren\u2019s syndrome. Genes and Immunity. 2009; 10: 285\u2013296.","DOI":"10.1038\/gene.2009.20"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, et al. Identification of a Sj\u00f6gren\u2019s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genetics. 2017; 13: e1006820.","DOI":"10.1371\/journal.pgen.1006820"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Huffman JE, Butler-Laporte G, Khan A, Pairo-Castineira E, Drivas TG, Peloso GM, et al. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. Nature Genetics. 2022; 54: 125\u2013127.","DOI":"10.1038\/s41588-021-00996-8"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Mentlein L, Thorlacius GE, Meneghel L, Aqrawi LA, Ram\u00edrez Sep\u00falveda JI, Grunewald J, et al. The rheumatic disease-associated FAM167A-BLK locus encodes DIORA-1, a novel disordered protein expressed highly in bronchial epithelium and alveolar macrophages. Clinical and Experimental Immunology. 2018; 193: 167\u2013177.","DOI":"10.1111\/cei.13138"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Hjelmervik TOR, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sj\u00f6gren\u2019s syndrome patients from healthy control subjects. Arthritis and Rheumatism. 2005; 52: 1534\u20131544.","DOI":"10.1002\/art.21006"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Aqrawi LA, Ivanchenko M, Bj\u00f6rk A, Ram\u00edrez Sep\u00falveda JI, Imgenberg-Kreuz J, Kvarnstr\u00f6m M, et al. Diminished CXCR5 expression in peripheral blood of patients with Sj\u00f6gren\u2019s syndrome may relate to both genotype and salivary gland homing. Clinical and Experimental Immunology. 2018; 192: 259\u2013270.","DOI":"10.1111\/cei.13118"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Ciccacci C, Latini A, Perricone C, Conigliaro P, Colafrancesco S, Ceccarelli F, et al. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients. Journal of Immunology Research. 2019; 2019: 6728694.","DOI":"10.1155\/2019\/6728694"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Puspitaningrum AN, Perwitasari DA, Adikusuma W, Djalilah GN, Dania H, Maliza R, et al. Integration of genomic databases and bioinformatic approach to identify genomic variants for sjogren\u2019s syndrome on multiple continents. Media Farmasi: Jurnal Ilmu Farmasi. 2022; 19: 71\u201381.","DOI":"10.12928\/mf.v19i2.23706"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Flessa CM, Zampeli E, Evangelopoulos ME, Natsis V, Bodewes ILA, Huijser E, et al. Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sj\u00f6gren\u2019s Syndrome. Frontiers in Immunology. 2022; 13: 836824.","DOI":"10.3389\/fimmu.2022.836824"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Casad\u00f3-Llombart S, Gheitasi H, Ari\u00f1o S, Consuegra-Fern\u00e1ndez M, Armiger-Borr\u00e0s N, Kostov B, et al. Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sj\u00f6gren\u2019s Syndrome. Frontiers in Medicine. 2022; 9: 822290.","DOI":"10.3389\/fmed.2022.822290"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Li M, Shi Y, Zhao J, Wang Q, Li M, Zhao X. Identification of potential susceptibility genes in patients with primary Sj\u00f6gren\u2019s syndrome-associated pulmonary arterial hypertension through whole exome sequencing. Arthritis Research & Therapy. 2023; 25: 175.","DOI":"10.1186\/s13075-023-03171-y"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Crick F. Central dogma of molecular biology. Nature. 1970; 227: 561\u2013563.","DOI":"10.1038\/227561a0"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Kapranov P, St Laurent G. Dark Matter RNA: Existence, Function, and Controversy. Frontiers in Genetics. 2012; 3: 60.","DOI":"10.3389\/fgene.2012.00060"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Fabbri M, Girnita L, Varani G, Calin GA. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Research. 2019; 29: 1377\u20131388.","DOI":"10.1101\/gr.247239.118"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011; 473: 337\u2013342.","DOI":"10.1038\/nature10098"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Pastva O, Klein K. Long Non-Coding RNAs in Sj\u00f6gren\u2019s Disease. International Journal of Molecular Sciences. 2024; 25: 5162.","DOI":"10.3390\/ijms25105162"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Cross T, Haug KBF, Brusletto BS, Ommundsen SK, Tr\u00f8seid AMS, Aspelin T, et al. Non-Coding RNA in Salivary Extracellular Vesicles: A New Frontier in Sj\u00f6gren\u2019s Syndrome Diagnostics? International Journal of Molecular Sciences. 2023; 24: 13409.","DOI":"10.3390\/ijms241713409"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Iacomino G. miRNAs: The Road from Bench to Bedside. Genes. 2023; 14: 314.","DOI":"10.3390\/genes14020314"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Pauley KM, Stewart CM, Gauna AE, Dupre LC, Kuklani R, Chan AL, et al. Altered miR-146a expression in Sj\u00f6gren\u2019s syndrome and its functional role in innate immunity. European Journal of Immunology. 2011; 41: 2029\u20132039.","DOI":"10.1002\/eji.201040757"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Zilahi E, Tarr T, Papp G, Griger Z, Sipka S, Zeher M. Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sj\u00f6gren\u2019s syndrome. Immunology Letters. 2012; 141: 165\u2013168.","DOI":"10.1016\/j.imlet.2011.09.006"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Shi H, Zheng LY, Zhang P, Yu CQ. miR-146a and miR-155 expression in PBMCs from patients with Sj\u00f6gren\u2019s syndrome. Journal of Oral Pathology & Medicine. 2014; 43: 792\u2013797.","DOI":"10.1111\/jop.12187"},{"key":"ref62","unstructured":"Jiang CR, Li HL. The value of MiR-146a and MiR-4484 expressions in the diagnosis of anti-SSA antibody positive Sjogren syndrome and the correlations with prognosis. European Review for Medical and Pharmacological Sciences. 2018; 22: 4800\u20134805."},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sj\u00f6gren\u2019s syndrome. Annals of the Rheumatic Diseases. 2018; 77: 133\u2013140.","DOI":"10.1136\/annrheumdis-2017-211417"},{"key":"ref64","unstructured":"Talotta R, Mercurio V, Bongiovanni S, Vittori C, Boccassini L, Rigamonti F, et al. Evaluation of salivary and plasma microRNA expression in patients with Sj\u00f6gren\u2019s syndrome, and correlations with clinical and ultrasonographic outcomes. Clinical and Experimental Rheumatology. 2019; 37: 70\u201377."},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Chen JQ, Zilahi E, Papp G, Sipka S, Zeher M. Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sj\u00f6gren\u2019s syndrome. International Journal of Rheumatic Diseases. 2017; 20: 609\u2013613.","DOI":"10.1111\/1756-185X.12804"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Ibrahim SA, Afify AY, Fawzy IO, El-Ekiaby N, Abdelaziz AI. The curious case of miR-155 in SLE. Expert Reviews in Molecular Medicine. 2021; 23: e11.","DOI":"10.1017\/erm.2021.11"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Peng L, Ma W, Yi F, Yang YJ, Lin W, Chen H, et al. MicroRNA profiling in Chinese patients with primary Sj\u00f6gren syndrome reveals elevated miRNA-181a in peripheral blood mononuclear cells. The Journal of Rheumatology. 2014; 41: 2208\u20132213.","DOI":"10.3899\/jrheum.131154"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Gourzi VC, Kapsogeorgou EK, Kyriakidis NC, Tzioufas AG. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro\/SSA and La\/SSB in primary Sj\u00f6gren\u2019s Syndrome. Clinical and Experimental Immunology. 2015; 182: 14\u201322.","DOI":"10.1111\/cei.12664"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Kapsogeorgou EK, Papageorgiou A, Protogerou AD, Voulgarelis M, Tzioufas AG. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sj\u00f6gren\u2019s syndrome. Annals of the Rheumatic Diseases. 2018; 77: 1200\u20131207.","DOI":"10.1136\/annrheumdis-2017-212639"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO. B-cell tolerance breakdown in Sj\u00f6gren\u2019s syndrome: focus on BAFF. Autoimmunity Reviews. 2010; 9: 604\u2013608.","DOI":"10.1016\/j.autrev.2010.05.006"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Vogelsang P, Jonsson MV, Dalvin ST, Appel S. Role of dendritic cells in Sj\u00f6gren\u2019s syndrome. Scandinavian Journal of Immunology. 2006; 64: 219\u2013226.","DOI":"10.1111\/j.1365-3083.2006.01811.x"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Lopes AP, van Roon JAG, Blokland SLM, Wang M, Chouri E, Hartgring SAY, et al. MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sj\u00f6gren\u2019s Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1. Frontiers in Immunology. 2019; 10: 1335.","DOI":"10.3389\/fimmu.2019.01335"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sj\u00f6gren\u2019s syndrome: Pathogenicity and plasticity. Journal of Autoimmunity. 2018; 87: 16\u201325.","DOI":"10.1016\/j.jaut.2017.11.003"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Calkia A, Gakiopoulou H, Theochari I, Foukas PG, Vassilopoulos D, Petras D. TGF-\u03b21\/Smad Signalling in Proliferative Glomerulonephritis Associated with Autoimmune Diseases. Mediterranean Journal of Rheumatology. 2022; 33: 176\u2013184.","DOI":"10.31138\/mjr.33.2.176"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Wang J, Wang X, Wang L, Sun C, Xie C, Li Z. MiR-let-7d-3p regulates IL-17 expression through targeting AKT1\/mTOR signaling in CD4+ T cells. In Vitro Cellular & Developmental Biology. Animal. 2020; 56: 67\u201374.","DOI":"10.1007\/s11626-019-00409-5"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Alevizos I, Alexander S, Turner RJ, Illei GG. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sj\u00f6gren\u2019s syndrome. Arthritis and Rheumatism. 2011; 63: 535\u2013544.","DOI":"10.1002\/art.30131"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Jang SI, Tandon M, Teos L, Zheng C, Warner BM, Alevizos I. Dual function of miR-1248 links interferon induction and calcium signaling defects in Sj\u00f6gren\u2019s syndrome. EBioMedicine. 2019; 48: 526\u2013538.","DOI":"10.1016\/j.ebiom.2019.09.010"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Cortes-Troncoso J, Jang SI, Perez P, Hidalgo J, Ikeuchi T, Greenwell-Wild T, et al. T cell exosome-derived miR-142-3p impairs glandular cell function in Sj\u00f6gren\u2019s syndrome. JCI Insight. 2020; 5: e133497.","DOI":"10.1172\/jci.insight.133497"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Yang Y, Hou Y, Li J, Zhang F, Du Q. Characterization of antiapoptotic microRNAs in primary Sj\u00f6gren\u2019s syndrome. Cell Biochemistry and Function. 2020; 38: 1111\u20131118.","DOI":"10.1002\/cbf.3569"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Kim YJ, Yeon Y, Lee WJ, Shin YU, Cho H, Sung YK, et al. Comparison of MicroRNA Expression in Tears of Normal Subjects and Sj\u00f6gren Syndrome Patients. Investigative Ophthalmology & Visual Science. 2019; 60: 4889\u20134895.","DOI":"10.1167\/iovs.19-27062"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Pilson Q, Smith S, Jefferies CA, N\u00ed Gabhann-Dromgoole J, Murphy CC. miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome. Scientific Reports. 2020; 10: 7484.","DOI":"10.1038\/s41598-020-64422-5"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Panda AC. Circular RNAs Act as miRNA Sponges. Advances in Experimental Medicine and Biology. 2018; 1087: 67\u201379.","DOI":"10.1007\/978-981-13-1426-1_6"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Bose R, Ain R. Regulation of Transcription by Circular RNAs. Advances in Experimental Medicine and Biology. 2018; 1087: 81\u201394.","DOI":"10.1007\/978-981-13-1426-1_7"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Li H, Li K, Lai W, Li X, Wang H, Yang J, et al. Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2018; 480: 17\u201325.","DOI":"10.1016\/j.cca.2018.01.026"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Ouyang Q, Wu J, Jiang Z, Zhao J, Wang R, Lou A, et al. Microarray Expression Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 2017; 42: 651\u2013659.","DOI":"10.1159\/000477883"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Iparraguirre L, Mu\u00f1oz-Culla M, Prada-Luengo I, Castillo-Trivi\u00f1o T, Olascoaga J, Otaegui D. Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis. Human Molecular Genetics. 2017; 26: 3564\u20133572.","DOI":"10.1093\/hmg\/ddx243"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Su LC, Xu WD, Liu XY, Fu L, Huang AF. Altered expression of circular RNA in primary Sj\u00f6gren\u2019s syndrome. Clinical Rheumatology. 2019; 38: 3425\u20133433.","DOI":"10.1007\/s10067-019-04728-6"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y, et al. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Research. 2018; 46: D106\u2013D112.","DOI":"10.1093\/nar\/gkx891"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Li F, Liu Z, Zhang B, Jiang S, Wang Q, Du L, et al. Circular RNA sequencing indicates circ-IQGAP2 and circ-ZC3H6 as noninvasive biomarkers of primary Sj\u00f6gren\u2019s syndrome. Rheumatology. 2020; 59: 2603\u20132615.","DOI":"10.1093\/rheumatology\/keaa163"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Zhang XO, Dong R, Zhang Y, Zhang JL, Luo Z, Zhang J, et al. Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Research. 2016; 26: 1277\u20131287.","DOI":"10.1101\/gr.202895.115"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Colombo M, Raposo G, Th\u00e9ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual Review of Cell and Developmental Biology. 2014; 30: 255\u2013289.","DOI":"10.1146\/annurev-cellbio-101512-122326"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Hedman AC, Smith JM, Sacks DB. The biology of IQGAP proteins: beyond the cytoskeleton. EMBO Reports. 2015; 16: 427\u2013446.","DOI":"10.15252\/embr.201439834"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, et al. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulmonary Medicine. 2015; 15: 147.","DOI":"10.1186\/s12890-015-0142-8"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Zou Y, Xu H. Involvement of long noncoding RNAs in the pathogenesis of autoimmune diseases. Journal of Translational Autoimmunity. 2020; 3: 100044.","DOI":"10.1016\/j.jtauto.2020.100044"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Uszczynska-Ratajczak B, Lagarde J, Frankish A, Guig\u00f3 R, Johnson R. Towards a complete map of the human long non-coding RNA transcriptome. Nature Reviews. Genetics. 2018; 19: 535\u2013548.","DOI":"10.1038\/s41576-018-0017-y"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Heidari-Ezzati S, Moeinian P, Ahmadian-Nejad B, Maghbbouli F, Abbasi S, Zahedi M, et al. The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function. Frontiers in Cell and Developmental Biology. 2024; 12: 1308730.","DOI":"10.3389\/fcell.2024.1308730"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Loda A, Collombet S, Heard E. Gene regulation in time and space during X-chromosome inactivation. Nature Reviews. Molecular Cell Biology. 2022; 23: 231\u2013249.","DOI":"10.1038\/s41580-021-00438-7"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Shaw TM, Zhang W, McCoy SS, Pagenkopf A, Carp DM, Garg S, et al. X-linked genes exhibit miR6891-5p-regulated skewing in Sj\u00f6gren\u2019s syndrome. Journal of Molecular Medicine. 2022; 100: 1253\u20131265.","DOI":"10.1007\/s00109-022-02205-3"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Dou DR, Zhao Y, Belk JA, Zhao Y, Casey KM, Chen DC, et al. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell. 2024; 187: 733\u2013749.e16.","DOI":"10.1016\/j.cell.2023.12.037"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"De Benedittis G, Ciccacci C, Latini A, Novelli L, Novelli G, Borgiani P. Emerging Role of microRNAs and Long Non-Coding RNAs in Sj\u00f6gren\u2019s Syndrome. Genes. 2021; 12: 903.","DOI":"10.3390\/genes12060903"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Wang J, Peng H, Tian J, Ma J, Tang X, Rui K, et al. Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sj\u00f6gren syndrome. Immunologic Research. 2016; 64: 489\u2013496.","DOI":"10.1007\/s12026-015-8715-4"},{"key":"ref102","unstructured":"Brito-Zer\u00f3n P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, et al. How immunological profile drives clinical phenotype of primary Sj\u00f6gren\u2019s syndrome at diagnosis: analysis of 10,500 patients (Sj\u00f6gren Big Data Project). Clinical and Experimental Rheumatology. 2018; 36: 102\u2013112."},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Joachims ML, Khatri B, Li C, Tessneer KL, Ice JA, Stolarczyk AM, et al. Dysregulated long non-coding RNA in Sj\u00f6gren\u2019s disease impacts both interferon and adaptive immune responses. RMD Open. 2022; 8: e002672.","DOI":"10.1136\/rmdopen-2022-002672"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Park YJ, Yoo SA, Kim M, Kim WU. The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases. Frontiers in Immunology. 2020; 11: 195.","DOI":"10.3389\/fimmu.2020.00195"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Inamo J, Suzuki K, Takeshita M, Kassai Y, Takiguchi M, Kurisu R, et al. Identification of novel genes associated with dysregulation of B cells in patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Research & Therapy. 2020; 22: 153.","DOI":"10.1186\/s13075-020-02248-2"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Ye L, Shi H, Yu C, Fu J, Chen C, Wu S, et al. LncRNA Neat1 positively regulates MAPK signaling and is involved in the pathogenesis of Sj\u00f6gren\u2019s syndrome. International Immunopharmacology. 2020; 88: 106992.","DOI":"10.1016\/j.intimp.2020.106992"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Fu J, Shi H, Wang B, Zhan T, Shao Y, Ye L, et al. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4+ T cell activation and Sj\u00f6gren\u2019s syndrome-like autoimmune response. Journal of Autoimmunity. 2020; 107: 102358.","DOI":"10.1016\/j.jaut.2019.102358"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"An Q, Zhao J, Zhu X, Yang B, Wu Z, Su Y, et al. Exploiting the role of T cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome for therapeutic treatment. Frontiers in Immunology. 2022; 13: 995895.","DOI":"10.3389\/fimmu.2022.995895"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Peng Y, Luo X, Chen Y, Peng L, Deng C, Fei Y, et al. LncRNA and mRNA expression profile of peripheral blood mononuclear cells in primary Sj\u00f6gren\u2019s syndrome patients. Scientific Reports. 2020; 10: 19629.","DOI":"10.1038\/s41598-020-76701-2"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Dolcino M, Tinazzi E, Vitali C, Del Papa N, Puccetti A, Lunardi C. Long Non-Coding RNAs Modulate Sj\u00f6gren\u2019s Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease. Journal of Clinical Medicine. 2019; 8: 1349.","DOI":"10.3390\/jcm8091349"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sj\u00f6gren\u2019s syndrome. Arthritis Research & Therapy. 2016; 18: 109.","DOI":"10.1186\/s13075-016-1005-2"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D. Pathogenesis and treatment of Sjogren\u2019s syndrome: Review and update. Frontiers in Immunology. 2023; 14: 1127417.","DOI":"10.3389\/fimmu.2023.1127417"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Paunovska K, Loughrey D, Dahlman JE. Drug delivery systems for RNA therapeutics. Nature Reviews. Genetics. 2022; 23: 265\u2013280.","DOI":"10.1038\/s41576-021-00439-4"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004; 431: 343\u2013349.","DOI":"10.1038\/nature02873"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Pauley KM, Cha S. RNAi Therapeutics in Autoimmune Disease. Pharmaceuticals. 2013; 6: 287\u2013294.","DOI":"10.3390\/ph6030287"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clinical Microbiology Reviews. 2008; 21: 583\u2013593.","DOI":"10.1128\/CMR.00008-08"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Muller RY, Hammond MC, Rio DC, Lee YJ. An Efficient Method for Electroporation of Small Interfering RNAs into ENCODE Project Tier 1 GM12878 and K562 Cell Lines. Journal of Biomolecular Techniques. 2015; 26: 142\u2013149.","DOI":"10.7171\/jbt.15-2604-003"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Sargazi S, Arshad R, Ghamari R, Rahdar A, Bakhshi A, Karkan SF, et al. siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review. Cell Biology International. 2022; 46: 1320\u20131344.","DOI":"10.1002\/cbin.11841"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Kumari A, Kaur A, Aggarwal G. The emerging potential of siRNA nanotherapeutics in treatment of arthritis. Asian Journal of Pharmaceutical Sciences. 2023; 18: 100845.","DOI":"10.1016\/j.ajps.2023.100845"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Rettig GR, Behlke MA. Progress toward in vivo use of siRNAs-II. Molecular Therapy: the Journal of the American Society of Gene Therapy. 2012; 20: 483\u2013512.","DOI":"10.1038\/mt.2011.263"},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"Arany S, Xu Q, Hernady E, Benoit DSW, Dewhurst S, Ovitt CE. Pro-apoptotic gene knockdown mediated by nanocomplexed siRNA reduces radiation damage in primary salivary gland cultures. Journal of Cellular Biochemistry. 2012; 113: 1955\u20131965.","DOI":"10.1002\/jcb.24064"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Arany S, Benoit DSW, Dewhurst S, Ovitt CE. Nanoparticle-mediated gene silencing confers radioprotection to salivary glands in vivo. Molecular Therapy: the Journal of the American Society of Gene Therapy. 2013; 21: 1182\u20131194.","DOI":"10.1038\/mt.2013.42"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Pauley KM, Gauna AE, Grichtchenko II, Chan EKL, Cha S. A secretagogue-small interfering RNA conjugate confers resistance to cytotoxicity in a cell model of Sj\u00f6gren\u2019s syndrome. Arthritis and Rheumatism. 2011; 63: 3116\u20133125.","DOI":"10.1002\/art.30450"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Das T, Chen Z, Hendriks RW, Kool M. A20\/Tumor Necrosis Factor \u03b1-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models. Frontiers in Immunology. 2018; 9: 104.","DOI":"10.3389\/fimmu.2018.00104"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Sisto M, Barca A, Lofrumento DD, Lisi S. Downstream activation of NF-\u03baB in the EDA-A1\/EDAR signalling in Sj\u00f6gren\u2019s syndrome and its regulation by the ubiquitin-editing enzyme A20. Clinical and Experimental Immunology. 2016; 184: 183\u2013196.","DOI":"10.1111\/cei.12764"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"Ciccacci C, Latini A, Perricone C, Conigliaro P, Colafrancesco S, Ceccarelli F, et al. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients. Journal of Immunology Research. 2019; 2019: 6728694.","DOI":"10.1155\/2019\/6728694"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000; 289: 2350\u20132354.","DOI":"10.1126\/science.289.5488.2350"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Sisto M, Lisi S, D\u2019Amore M, Lofrumento DD. Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-\u03baB in Sj\u00f6gren syndrome. Immunology. 2014; 143: 42\u201351.","DOI":"10.1111\/imm.12288"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Son GY, Zou A, Wahl A, Huang KT, Vinu M, Zorgit S, et al. Loss of STIM1 and STIM2 in salivary glands disrupts ANO1 function but does not induce Sjogren\u2019s disease. BioRxiv. 2024. (preprint)","DOI":"10.1101\/2024.01.08.574702"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/12\/10.31083\/j.fbl2912403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:38:52Z","timestamp":1735558732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/12\/10.31083\/j.fbl2912403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":129,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2768-6701(24)01413-8"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2912403","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"article-number":"403"}}